SCHEMBL2172966

SCHEMBL2172966

CC(C)c1ccc(CC(=O)NCc2nc(C(=O)NCCc3cccc(Cl)c3)cs2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.51
ALDH1A1 P00352 4/20 0.51
KMT2A Q03164 3/20 0.51
MEN1 O00255 2/20 0.51
HPGD P15428 1/20 0.51
IGF1R P08069 1/20 0.49
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
HTT P42858 3/20 0.45
HIF1A Q16665 2/20 0.44
SLC2A1 P11166 1/20 0.44
GAA P10253 1/20 0.42
MAPT P10636 3/20 0.41
THRB P10828 1/20 0.41
IDO1 P14902 1/20 0.41
CYP3A4 P08684 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5668362 0.89 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1KMT2AMEN1HPGD
SCHEMBL2174484 0.88 IGF1R (0.49) SMN1; SMN2KMT2AMEN1IGF1RNPC1
SCHEMBL2173689 0.87 CNR1 (0.53) SMN1; SMN2ALDH1A1KMT2AMEN1IGF1R
SCHEMBL5670028 0.83 IGF1R (0.56) SMN1; SMN2ALDH1A1KMT2AMEN1HPGD
SCHEMBL5668546 0.80 IGF1R (0.49) SMN1; SMN2KMT2AMEN1IGF1RNPC1
SCHEMBL5668870 0.80 IGF1R (0.51) SMN1; SMN2ALDH1A1KMT2AMEN1HPGD
SCHEMBL2171406 0.80 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1KMT2AMEN1HPGD
SCHEMBL10126403 0.79 IGF1R (0.52) SMN1; SMN2ALDH1A1KMT2AMEN1HPGD
SCHEMBL2174354 0.79 HDAC3 (0.52) SMN1; SMN2ALDH1A1KMT2AMEN1IGF1R
SCHEMBL2172958 0.79 CNR1 (0.54) SMN1; SMN2ALDH1A1KMT2AMEN1IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973061-B2 Anaplastic lymphoma kinase modulators and methods of use EXELIXIS, INC. (US) 2011-07-05 US disclosed